Skip to main content
Top
Published in: International Urology and Nephrology 5/2013

01-10-2013 | Nephrology - Original Paper

Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study

Authors: Li-Yan Wang, Dao-Xin Yin, Dong-Liang Zhang, Rui Xu, Wen-Ying Cui, Wen-Hu Liu

Published in: International Urology and Nephrology | Issue 5/2013

Login to get access

Abstract

Purpose

Hypertension is an independent risk factor for mortality in chronic kidney disease (CKD) and is suboptimally controlled worldwide. Therefore, this study aimed to examine the rate of BP control and the main barriers to achieving target BP, according to K/DOQI guidelines, in China.

Methods

We performed a single-center, prospective cohort study. Two hundred and sixty CKD patients were referred by general physicians to nephrologists, and their BP was treated in accordance with K/DOQI guidelines for a 1-year follow-up. We evaluated improvement of BP target achievement and factors affecting BP control. We defined “not-at-goal” as persistence of systolic BP ≥ 130 mmHg and/or diastolic BP ≥ 80 mmHg after 1 year.

Results

The BP decreased from 138 ± 12/84 ± 7 mmHg at baseline to 124 ± 13/73 ± 7 mmHg after 1 year. The rate of achieving the BP goal (<130/80 mmHg) increased from 25.4 to 61.5 %. The decrease in BP was associated with a significant reduction of proteinuria (median, 0.14 vs 0.06 g/24 h; P < 0.05). Logistic regression analysis identified proteinuria levels ≥1.0 g/24 h (odds ratio [OR]: 5.21; 95 % confidence interval [CI]: 1.37–19.77) and high basal systolic BP (OR: 2.17; 95 % CI: 1.25–3.77) and diastolic BP (OR: 6.62; 95 % CI: 2.03–21.60) as independent predictors of not-at-goal BP. Higher educational level was independently associated with at-goal BP (OR: 0.21; 95 % CI: 0.06–0.78).

Conclusions

In CKD patients, BP control is poor when managed by general physicians and may be improved after nephrologist referral. High basal BP and proteinuria levels ≥1.0 g/24 h are the main barriers that preclude the optimal control of BP.
Literature
1.
go back to reference Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG (2003) Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115:291–297PubMedCrossRef Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG (2003) Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115:291–297PubMedCrossRef
2.
go back to reference Paraskevas KI, Kotsikoris I, Koupidis SA, Tzovaras AA, Mikhailidis DP (2010) Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. Int Urol Nephrol 42:999–1006PubMedCrossRef Paraskevas KI, Kotsikoris I, Koupidis SA, Tzovaras AA, Mikhailidis DP (2010) Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. Int Urol Nephrol 42:999–1006PubMedCrossRef
3.
go back to reference Agarwal R, Andersen MJ (2006) Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol 26:503–510PubMedCrossRef Agarwal R, Andersen MJ (2006) Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol 26:503–510PubMedCrossRef
4.
go back to reference Cui H, Wang F, Fan L, Hu YX, Hu GL, Liu L, Hong CM (2011) Association factors of target organ damage: analysis of 17,682 elderly hypertensive patients in China. Chin Med J 124:3676–3681PubMed Cui H, Wang F, Fan L, Hu YX, Hu GL, Liu L, Hong CM (2011) Association factors of target organ damage: analysis of 17,682 elderly hypertensive patients in China. Chin Med J 124:3676–3681PubMed
5.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572PubMedCrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572PubMedCrossRef
6.
go back to reference Peralta CA, Hicks LS, Chertow GM, Ayanian JZ, Vittinghoff E, Lin F, Shlipak MG (2005) Control of hypertension in adults with chronic kidney disease in the United States. Hypertension 45:1119–1124PubMedCrossRef Peralta CA, Hicks LS, Chertow GM, Ayanian JZ, Vittinghoff E, Lin F, Shlipak MG (2005) Control of hypertension in adults with chronic kidney disease in the United States. Hypertension 45:1119–1124PubMedCrossRef
7.
go back to reference Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, Arfe G, Boschi G, Brancati C, Iaccarino P, Conte G (2005) Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis 46:18–25PubMedCrossRef Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, Arfe G, Boschi G, Brancati C, Iaccarino P, Conte G (2005) Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis 46:18–25PubMedCrossRef
8.
go back to reference Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O’Connor A, Perumal K, Rahman M, Steigerwalt S, Teal V, Townsend R, Weir M, Wright JT Jr (2010) Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis 55:441–451PubMedCrossRef Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O’Connor A, Perumal K, Rahman M, Steigerwalt S, Teal V, Townsend R, Weir M, Wright JT Jr (2010) Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis 55:441–451PubMedCrossRef
10.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944PubMedCrossRef Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944PubMedCrossRef
11.
go back to reference WHO expert consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef WHO expert consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef
12.
go back to reference Cheng LT, Gao YL, Gu Y, Zhang L, Bi SH, Tang W, Wang T (2008) Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease. Nephrol Dial Transplant 23:3895–3900PubMedCrossRef Cheng LT, Gao YL, Gu Y, Zhang L, Bi SH, Tang W, Wang T (2008) Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease. Nephrol Dial Transplant 23:3895–3900PubMedCrossRef
13.
go back to reference Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16:180–188PubMedCrossRef Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16:180–188PubMedCrossRef
14.
15.
go back to reference Lindeman RD (2007) Hypertension and kidney protection in the elderly: what is the evidence in 2007? Int Urol Nephrol 39:669–678PubMedCrossRef Lindeman RD (2007) Hypertension and kidney protection in the elderly: what is the evidence in 2007? Int Urol Nephrol 39:669–678PubMedCrossRef
16.
go back to reference Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, Hague N, New J, Farmer CK (2007) Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 72:92–99PubMedCrossRef Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, Hague N, New J, Farmer CK (2007) Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 72:92–99PubMedCrossRef
17.
go back to reference Thilly N, Boini S, Kessler M, Briancon S, Frimat L (2009) Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l’Insuffisance Renale). Nephrol Dial Transplant 24:934–939PubMedCrossRef Thilly N, Boini S, Kessler M, Briancon S, Frimat L (2009) Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l’Insuffisance Renale). Nephrol Dial Transplant 24:934–939PubMedCrossRef
18.
go back to reference Wang Y, Zhang L, Li X, Xu Y, Yang M, Qian J, Wang L, Chen N, Gu Y, Chen M, Xing C, Chen X, Hou F, Yu X, Cheng X, Guo L, Wei C, Huang G, Zhang Q, Wang R, Wang L, Mei C, Li Y, Liu Z, Zhao L, Wu Y, Wang HY (2009) Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005. Hypertens Res 32:444–449PubMedCrossRef Wang Y, Zhang L, Li X, Xu Y, Yang M, Qian J, Wang L, Chen N, Gu Y, Chen M, Xing C, Chen X, Hou F, Yu X, Cheng X, Guo L, Wei C, Huang G, Zhang Q, Wang R, Wang L, Mei C, Li Y, Liu Z, Zhao L, Wu Y, Wang HY (2009) Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005. Hypertens Res 32:444–449PubMedCrossRef
19.
go back to reference Zhang AH, Zhong H, Tang W, Chen SY, He L, Wang S, Su CY, Lu XH, Wang T (2008) Establishing a renal management clinic in China: initiative, challenges, and opportunities. Int Urol Nephrol 40:1053–1058PubMedCrossRef Zhang AH, Zhong H, Tang W, Chen SY, He L, Wang S, Su CY, Lu XH, Wang T (2008) Establishing a renal management clinic in China: initiative, challenges, and opportunities. Int Urol Nephrol 40:1053–1058PubMedCrossRef
20.
go back to reference Bielak LF, Turner ST, Franklin SS, Sheedy PF 2nd, Peyser PA (2004) Age-dependent associations between blood pressure and coronary artery calcification in asymptomatic adults. J Hypertens 22:719–725PubMedCrossRef Bielak LF, Turner ST, Franklin SS, Sheedy PF 2nd, Peyser PA (2004) Age-dependent associations between blood pressure and coronary artery calcification in asymptomatic adults. J Hypertens 22:719–725PubMedCrossRef
21.
go back to reference Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942PubMedCrossRef Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942PubMedCrossRef
22.
go back to reference Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J (2002) Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 13:2776–2782PubMedCrossRef Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J (2002) Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 13:2776–2782PubMedCrossRef
23.
go back to reference Ogden LG, He J, Lydick E, Whelton PK (2000) Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35:539–543PubMedCrossRef Ogden LG, He J, Lydick E, Whelton PK (2000) Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35:539–543PubMedCrossRef
24.
go back to reference Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D (2007) Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 18:1540–1546PubMedCrossRef Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D (2007) Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 18:1540–1546PubMedCrossRef
25.
go back to reference Palmer BF (2008) Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease. Am J Nephrol 28:381–390PubMedCrossRef Palmer BF (2008) Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease. Am J Nephrol 28:381–390PubMedCrossRef
26.
go back to reference Siamopoulos KC, Kalaitzidis RG (2008) Inhibition of the renin-angiotensin system and chronic kidney disease. Int Urol Nephrol 40:1015–1025PubMedCrossRef Siamopoulos KC, Kalaitzidis RG (2008) Inhibition of the renin-angiotensin system and chronic kidney disease. Int Urol Nephrol 40:1015–1025PubMedCrossRef
27.
go back to reference Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG (2002) Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421–2431PubMedCrossRef Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG (2002) Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421–2431PubMedCrossRef
28.
go back to reference Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, Safar M (2002) Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15:1101–1108PubMedCrossRef Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, Safar M (2002) Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15:1101–1108PubMedCrossRef
29.
go back to reference de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921–927PubMedCrossRef de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921–927PubMedCrossRef
30.
go back to reference Persell SD, Osborn CY, Richard R, Skripkauskas S, Wolf MS (2007) Limited health literacy is a barrier to medication reconciliation in ambulatory care. J Gen Intern Med 22:1523–1526PubMedCrossRef Persell SD, Osborn CY, Richard R, Skripkauskas S, Wolf MS (2007) Limited health literacy is a barrier to medication reconciliation in ambulatory care. J Gen Intern Med 22:1523–1526PubMedCrossRef
Metadata
Title
Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study
Authors
Li-Yan Wang
Dao-Xin Yin
Dong-Liang Zhang
Rui Xu
Wen-Ying Cui
Wen-Hu Liu
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0332-8

Other articles of this Issue 5/2013

International Urology and Nephrology 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.